Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (2025)

Table of Contents
More Relevant Posts More from this author Explore topics

Amr El-Refaey CMI Level 7 Strategic Management Certificate

Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

  • Report this post

BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda!

BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda fiercepharma.com

9

Like Comment

To view or add a comment, sign in

More Relevant Posts

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    The World’s Most Innovative Countries in 2024!#innovation https://lnkd.in/ddbVHM3T

    • Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (5)

    5

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    Eli Lilly's Mounjaro & Zepbound have been removed from the FDA's shortage list!Meanwhile, shortages persist for Novo Nordisk's GLP-1 drugs Ozempic & Wegovy!

    See Also
    Antibiotic Use and Antimicrobial Resistance: A Global Public Health CrisisAntimicrobial Resistance: An updateMultimodal Role of Amino Acids in Microbial Control and Drug Development
    Eli Lilly's shortage of diabetes and obesity drugs is over, halting competition with knock-offs fiercepharma.com

    13

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    EHJ, September 2024!Semaglutide & blood pressure: an individual patient data meta analysis!

    29

    1 Comment

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    5 Essential Nutrients for Patients on GLP-1s!

    Five Essential Nutrients for Patients on GLP-1s medscape.com

    5

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    Stem cells reverse woman’s diabetes — a world first!

    Stem cells reverse woman’s diabetes — a world first nature.com

    6

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    Today, US FDA Approves Dupilumab as First Biologic Treatment for COPD!The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled COPD to significantly help reduce exacerbations & improve lung function.#innovation

    FDA Approves Dupilumab as First Biologic Treatment for COPD ajmc.com

    66

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    BMS scores first schizophrenia approval for non-dopamine drug!https://lnkd.in/dg_kmaff

    • Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (27)

    14

    2 Comments

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    GLP-1 Therapies: Revolutionizing Healthcare, Reshaping Costs!https://lnkd.in/dymj_rWG

    • Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (30)

    14

    1 Comment

    Like Comment

    To view or add a comment, sign in

  • Amr El-Refaey CMI Level 7 Strategic Management Certificate

    Passionate to embrace the future through transformative leadership & making a difference in people's lives Board Certified Biologics & Biosimilars Specialist (BCBBS)MBA Leicester University - UK

    • Report this post

    Why do obesity drugs seem to treat so many other ailments?From alcoholism to Parkinson’s, scientists are studying the mechanisms behind the broad clinical potential of weight-loss drugs!

    Why do obesity drugs seem to treat so many other ailments? nature.com

    10

    Like Comment

    To view or add a comment, sign in

Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (37)

Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (38)

13,903 followers

  • 2,620 Posts
  • 2 Articles

View Profile

Follow

More from this author

  • Biobetters! Better than what? Amr El-Refaey CMI Level 7 Strategic Management Certificate 4y
  • “Biosimilar” not “identical” this is true Amr El-Refaey CMI Level 7 Strategic Management Certificate 4y

Explore topics

  • Sales
  • Marketing
  • IT Services
  • Business Administration
  • HR Management
  • Engineering
  • Soft Skills
  • See All
Amr El-Refaey CMI Level 7 Strategic Management Certificate on LinkedIn: BeiGene launches PD-1 drug Tevimbra at 10% discount to Merck's Keytruda (2025)
Top Articles
Jackson Warne shows off 15kg weight loss transformation
UK trade secretary to visit China with aim of reviving key joint trade commission
What are the tire strategies for the F1 Saudi Arabian Grand Prix?
Latest Posts
Cherished companions, or cunning predators? Australia's debate over cats
Jack O’Connell on ‘Sinners,’ Honoring His Irish Heritage and Ryan Coogler: “He Cultivates Something Phenomenal”
Recommended Articles
Article information

Author: Lidia Grady

Last Updated:

Views: 5620

Rating: 4.4 / 5 (45 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Lidia Grady

Birthday: 1992-01-22

Address: Suite 493 356 Dale Fall, New Wanda, RI 52485

Phone: +29914464387516

Job: Customer Engineer

Hobby: Cryptography, Writing, Dowsing, Stand-up comedy, Calligraphy, Web surfing, Ghost hunting

Introduction: My name is Lidia Grady, I am a thankful, fine, glamorous, lucky, lively, pleasant, shiny person who loves writing and wants to share my knowledge and understanding with you.